Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bilibili Inc BILI

Bilibili Inc is a China-based company principally engaged in the Internet and other related businesses. The Company operates its business through four segments. The Mobile Games segment mainly publishes mobile games on its platform for third-party game developers which are free to download and play with Bilibili accounts. The Advertising segment is mainly engaged in display advertising arrangements business. The Live broadcasting and Value-added services (VAS) segment mainly generates revenue from subscription fee of premium membership program, sales of in-channel virtual items and sales of paid content and virtual items on its video, audio and comic platforms. The E-commerce and Others segment mainly engages in the online sales of anime, comics and games (AGG)-related merchandise and offline performance events and activities.


NDAQ:BILI - Post by User

<< Previous
Bullboard Posts
Next >>
Post by MitchelleTon Feb 04, 2022 10:47am
69 Views
Post# 34397494

FSD Pharma Inc: Lucid MS Video

FSD Pharma Inc: Lucid MS VideoFSD Pharma is pleased to share pre-clinical data demonstrating the effectiveness of its lead drug candidate, Lucid-MS, in treating Multiple Sclerosis. The unique potential therapeutic value of Lucid-MS is an industry-first and we want to share the visual evidence of functional recovery of pre-clinical subjects in this video!
<< Previous
Bullboard Posts
Next >>